Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC
Article Information
Publication Timeline
- Received02 January 2024
- Accepted05 February 2024
Abstract
A simple, rapid, specific and accurate reverse phase high performance liquid chromatographic method has been developed for the validated of Ibrutinib in bulk as well as in marketed pharmaceutical dosage form. This separation was performed on a Symmetry ODS C18 (4.6×250mm, 5µm) column with Methanol: Phosphate Buffer (35:65) v/v as mobile phase at a flow rate of 1.0 mL min−1 with UV detection at 235 nm; the constant column temperature was Ambient. The runtime under these chromatographic conditions was less than 8 min. The retention time of Ibrutinib was found to be 2.276min. The calibration plot was linear over the concentration range of 6–14 μg mL−1 with limits of detection and quantification values of 1.2 and 3.6 ng mL−1 respectively. The mean % assay of marketed formulation was found to be 99.86%, and % recovery was observed in the range of 98-102%. Relative standard deviation for the precision study was found <2%.The developed method is simple, precise, specific, accurate and rapid, making it suitable for estimation of Ibrutinib in bulk and marketed pharmaceutical dosage form dosage form.
References
- https://go.drugbank.com/drugs/DB09053 [Google Scholar][Crossref]
- https://pubchem.ncbi.nlm.nih.gov/compound/Ibrutinib [Google Scholar][Crossref]
- https://en.wikipedia.org/wiki/Ibrutinib [Google Scholar][Crossref]
- Weston A, Brown PR. HPLC: Principle and Practice. 1st ed. San Diego: Academic Press; 1997. p. 24-37. [Google Scholar][Crossref]
- Kazakevich Y, Lobrutto R. HPLC for Pharmaceutical Scientists. 1st ed. Hoboken: Wiley-Interscience; 2007. p. 15-23. [Google Scholar][Crossref]
- Kealey D, Haines PJ. Analytical Chemistry. 1st ed. Oxford: BIOS Scientific Publishers; 2002. p. 1-7. [Google Scholar][Crossref]
- Braithwaite A, Smith FJ. Chromatographic Methods. 5th ed. Dordrecht: Kluwer Academic Publishers; 1996. p. 1-2. [Google Scholar][Crossref]
- Chromatography. Available from: http://en.wikipedia.org/wiki/Chromatography [Google Scholar][Crossref]
- Meyer VR. Practical High-Performance Liquid Chromatography. 4th ed. Chichester: John Wiley & Sons Ltd; 2004. p. 7-8. [Google Scholar][Crossref]
- Sahajwalla CG. A New Drug Development. Vol. 141. New York: Marcel Dekker Inc.; 2004. p. 421-6. [Google Scholar][Crossref]
- Introduction to Column. Available from: http://amitpatel745.topcities.com/index_files/study/colu mn%20care.pdf [Google Scholar][Crossref]
- Detectors used in HPLC. Available from: http://wiki.answers.com/Q/What_detectors_are_used_in _HPLC [Google Scholar][Crossref]
- Detectors. Available from: http://hplc.chem.shu.edu/NEW/HPLC_Book/Detectors/det_uvda.html [Google Scholar][Crossref]
- Detectors. Available from: http://www.dionex.com/enus/webdocs/64842-31644-02_PDA-100.pdf [Google Scholar][Crossref]
- Detectors. Available from: https://www.ncbi.nlm.nih.gov/pubmed/8867705 [Google Scholar][Crossref]
- Detectors. Available from: http://www.chem.agilent.com/Library/applications/596 43559.pdf [Google Scholar][Crossref]
- Detectors. Available from: http://hplc.chem.shu.edu/new/hplcbook/detector [Google Scholar][Crossref]
- International Conference on Harmonisation (ICH). Draft ICH guidelines on validation of analytical procedures: Definitions and terminology. Federal Register. 1995;60:1126. [Google Scholar][Crossref]
- ICH Harmonised Tripartite Guideline. Validation of analytical procedures: Methodology (Q2B). Geneva, Switzerland; 1996. p. 1-8. [Google Scholar][Crossref]
- Introduction to analytical method validation. Available from: http://www.standardbase.hu/tech/HPLC%20validation %20PE.pdf [Google Scholar][Crossref]
- Data elements required for assay validation [Internet]. Available from: http://www.labcompliance.com/tutorial/methods/default .aspx [Google Scholar][Crossref]
- Snyder LR. Practical HPLC Method Development. 2nd ed. New York: John Wiley & Sons; 1997. p. 180-2. [Google Scholar][Crossref]
- Skoog DA, West DM, Holler FJ. Introduction to Analytical Chemistry. Philadelphia: Saunders College Publishing; 1994. p. 1-5. [Google Scholar][Crossref]
- Sharma BK. Instrumental Method of Chemical Analysis. Meerut: Goel Publishing House; 1999. p. 175-203. [Google Scholar][Crossref]
- Breaux J, Jones K. Understanding and implementing efficient analytical method development and validation. Journal of Pharmaceutical Technology. 2003;5:110-4. [Google Scholar][Crossref]
- Willard HH, Merritt LL, Dean JA, Settle FA. Instrumental Methods of Analysis. 7th ed. New Delhi: CBS Publishers and Distributors; 1991. p. 436-9. [Google Scholar][Crossref]
- ICH Q2A. Validation of analytical methods: Definitions and terminology. ICH Harmonised Tripartite Guideline; c1999. [Google Scholar][Crossref]
- Illendula S, Priyanka D, Shirisha V, Rao KNV, Dutt R. A new simple method development and validation of ibrutinib in bulk and pharmaceutical dosage form by RP-HPLC. International Journal of Pharmacy and Biological Sciences – IJPBSTM. 2019;9(1):36-46. [Google Scholar][Crossref]
- Kapavarapu S, Golkonda R, Chintala R. Validation of stability indicating RP-HPLC method for the assay of ibrutinib in pharmaceutical dosage form. Analytical Chemistry: An Indian Journal. 2016;16(1):7-19. [Google Scholar][Crossref]
- Uppala V, Divya N, Charishma E, Harshavardan K, Shyamala M. Validated stability-indicating RP-HPLC method for determination of ibrutinib. Indo American Journal of Pharmaceutical Sciences. 2016;3(4):324-30. [Google Scholar][Crossref]
- Mehta L, Naved T, Grover P, Bhardwaj M, Mukherjee D. Development and validation of novel and highly sensitive stability-indicating reverse phase ultra-performance liquid chromatography method for quantification of ibrutinib and its ten degradation products. Indian Journal of Pharmaceutical Sciences. 2020;82(6):958–66. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Copyright and License © 2026 The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]
How to Cite
Vishwanath, D., Sarkar, P., Islam, A., Salmankhan, & Sarkar, S. (2024). Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC. International Journal of Medical and All Body Health Research, 5(1), 31-37.
Vishwanath, D, et al. "Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC." International Journal of Medical and All Body Health Research, vol. 5, no. 1, 2024, pp. 31-37.
Vishwanath, D., Sarkar, P., Islam, A., Salmankhan and Sarkar, S. (2024) 'Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC', International Journal of Medical and All Body Health Research, 5(1), pp. 31-37.
Vishwanath D, Sarkar P, Islam A, Salmankhan, Sarkar S. Analytical method development and validation for the quantitative analysis of Ibrutinib in API form and marketed pharmaceutical dosage form by using RP-HPLC. International Journal of Medical and All Body Health Research. 2024;5(1):31-37.
Similar Articles
- An Interpretable XGBoost Model for Diabetes Prediction: Nested Cross-Validation, Calibration, and SHAP Analysis Vol 7, Issue 3 (2026)
- Development and validation of a new analytical RP-HPLC method for the determination of flavoxate hydrochloride in bulk form and pharmaceutical dosage form Vol 5, Issue 1 (2024)
- A new analytical novel RP-HPLC method development and validation for the quantitative determination of Dasatinib in pure form and marketed pharmaceutical dosage form Vol 5, Issue 2 (2024)
- RP-HPLC Method Development and Validation for the Quantitative Determination of Ruxolitinib in Pure Form and Marketed Pharmaceutical Dosage Form Vol 5, Issue 2 (2024)
- Formulation and in vitro evaluation of Diltiazem controlled release tablets Vol 5, Issue 1 (2024)
Find this Article on
Google Scholar Semantic Scholar OpenAlex ResearchGate BASEA newly published article may take a few days to appear on these services.